As of May 2024 Perspective Therapeutics has a market cap of $1.06 Billion. This makes Perspective Therapeutics the world's 5070th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.06 B | 841.86% |
2023 | $0.11 B | 221.19% |
2022 | $35.11 M | -36.25% |
2021 | $55.08 M | 40.32% |
2020 | $39.25 M | -6.71% |
2019 | $42.07 M | 108.31% |
2018 | $20.19 M | -8.05% |
2017 | $21.96 M | -31.16% |
2016 | $31.91 M | -38.13% |
2015 | $51.57 M | -35.64% |
2014 | $80.12 M | 317.13% |
2013 | $19.2 M | -28.82% |
2012 | $26.98 M | 39.48% |
2011 | $19.34 M | -33.71% |
2010 | $29.18 M | 42.96% |
2009 | $20.41 M | 344.95% |
2008 | $4.58 M | -90.11% |
2007 | $46.41 M | -41.88% |
2006 | $79.85 M | -17.7% |
2005 | $97.02 M | -82.5% |
2004 | $0.55 B | -43.88% |
2003 | $0.98 B |
On May 4th, 2024 the market cap of Perspective Therapeutics was reported to be: